Mark was Chief Executive Officer at Versanis Bio, and Chief Executive Officer and Director at Intercept Pharmaceuticals. Mark Pruzanski joined Eli Lilly in 2023.
Mark Pruzanski is currently
Create your alert
to follow the career of Mark Pruzanski.
Mark Pruzanski has a Master of Arts in International Relations and Affairs from Johns Hopkins School of Advanced International Studies and a Doctor of Medicine from McMaster University.
They have also studied at McMaster University :
Find more alumni from McMaster University
Do you need to know more about Mark Pruzanski? More results.
Report an error
Update the org chart details of Mark Pruzanski.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.